{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:06:31Z","timestamp":1771682791431,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jns.2026.125819","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:36:11Z","timestamp":1770914171000},"page":"125819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Authors response to Comment on \u201cPlasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis\u201d"],"prefix":"10.1016","volume":"482","author":[{"given":"Valerio","family":"Nicolella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.125819_bb0005","series-title":"Journal of the Neurological Sciences Comment on \u201cPlasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis\u201d","author":"Urolagin","year":"2025"},{"key":"10.1016\/j.jns.2026.125819_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.125681","article-title":"Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis","volume":"480","author":"Nicolella","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125819_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/13524585251407973","article-title":"Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)\u2014a meta-regression of randomized controlled trials","author":"Pretzsch","year":"2026","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2026.125819_bb0020","article-title":"Moderate\u2013high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis","author":"Foong","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2026.125819_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-024-12434-w","article-title":"The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis","author":"Monteiro","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125819_bb0030","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1093\/brain\/awaf331","article-title":"Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types","volume":"148","author":"Willard","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.jns.2026.125819_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-025-03674-2","article-title":"Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis","volume":"23","author":"Inojosa","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2026.125819_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251364018","article-title":"Advancing clinical use of neurofilament light chain: translational insights from research to routine practice","volume":"20","author":"La Civita","year":"2025","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.jns.2026.125819_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/13524585241246536","article-title":"Neurofilament in clinical practice: is the multiple sclerosis community ready?","volume":"30","author":"Moccia","year":"2024","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2026.125819_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13223-9","article-title":"Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis","volume":"272","author":"Nicolella","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125819_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00812","article-title":"Switching from anti-CD20 therapies to cladribine and vice versa \u2013 analysis of a German relapsing multiple sclerosis cohort","author":"Konen","year":"2025","journal-title":"Neurotherapeutics"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:31:49Z","timestamp":1771680709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":11,"alternative-id":["S0022510X26001012"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125819","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Authors response to Comment on \u201cPlasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125820","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125819"}}